Tenon Medical Enters Warrant Inducement Deal, Issues Series B Warrants

What Happened

• Tenon Medical, Inc. announced on September 11, 2026 that it entered into an inducement agreement with a holder of Series A warrants, under which the holder agreed to exercise Existing Warrants for cash and the Company issued new unregistered five‑year Series B Common Stock Purchase Warrants. The Existing Warrants (issued August 31, 2026) cover 572,179 shares and were exercisable at $5.02 per share; the aggregate exercise price for those Existing Warrants is approximately $2,872,339. The New Warrants allow the holder to purchase up to 858,269 shares (150% of the Existing Warrants’ underlying shares) at $5.02 per share and expire five years from issuance.

Key Details

• Date of Inducement Agreement: September 11, 2026; press releases announced Sept 11 and closing on Sept 14, 2026.
• Existing Warrants: 572,179 shares; aggregate exercise price ≈ $2,872,339; exercise price $5.02/share.
• New Warrants: 858,269 shares (150% of underlying Existing Warrant shares); $5.02 exercise price; five‑year term; issued under Section 4(a)(2) (unregistered).
• Financial advisor: WallachBeth Capital LLC; fee = 7% of aggregate gross proceeds + up to $65,000 reimbursement for accountable legal expenses.
• Registration commitment: Company to file a resale registration statement for shares underlying the New Warrants within 30 days and use commercially reasonable efforts to have it effective within 60 days (90 days if SEC full review).
• Intended use of proceeds: working capital and general corporate purposes.

Why It Matters

• This transaction provides Tenon Medical with immediate cash from the exercise of the Existing Warrants (≈ $2.87M) while granting the investor additional long‑dated upside via New Warrants. For investors, key takeaways are potential dilution from the New Warrants (up to 858,269 shares if exercised) and costs tied to the deal (7% advisory fee plus legal reimbursements). The company’s commitment to file a resale registration statement is important because, until that registration is effective, the New Warrants and the shares they could convert into are restricted from public resale.